Morgado Afonso, Cavadas Ana Sofía, Pacheco Figueiredo Luis, Tomada Nuno
Serviço de Urologia, Centro Hospitalar São João, Porto, Portugal.
Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Rev Int Androl. 2018 Jul-Sep;16(3):112-118. doi: 10.1016/j.androl.2017.07.003. Epub 2017 Oct 16.
Erectile dysfunction (ED) is one of the most prevalent male sexual disorders worldwide. When conservative treatment is unsuccessful, contraindicated or causes unacceptable side effects penile prosthesis implantation is a definitive option for the management of ED. Although considered a third-line therapy, it achieves the highest satisfaction rates as compared with non-surgical treatment. Three-piece inflatable penile prothesis (IPP) represents the most sophisticated implantable device, AMS 700CX™ and Coloplast Titan being the two most commonly used. Although there are several studies evaluating patient satisfaction with either model, there is little published data comparing both models.
We have compared overall patient satisfaction in 55 patients submitted to either 700CX™ or Titan implantation. The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire was used to access patient satisfaction.
Patient mean age and follow-up time were 59.1 years and 57.9 months respectively. There was no difference in EDITS score between 700CX™ and Titan IPP (77.2±12.1 versus 77.5±16.6 respectively, p=0.956).
Overall patient satisfaction as assessed by EDITS questionnaire was not different between 700CX™ and Titan.
勃起功能障碍(ED)是全球最常见的男性性功能障碍之一。当保守治疗失败、禁忌或引起不可接受的副作用时,阴茎假体植入是治疗ED的最终选择。尽管被视为三线治疗,但与非手术治疗相比,它能达到最高的满意率。三件式可膨胀阴茎假体(IPP)是最复杂的可植入装置,AMS 700CX™和科洛普拉斯泰坦(Coloplast Titan)是最常用的两种。尽管有几项研究评估了患者对这两种型号的满意度,但比较这两种型号的已发表数据很少。
我们比较了55例接受700CX™或泰坦植入术患者的总体满意度。使用勃起功能障碍治疗满意度量表(EDITS)问卷来评估患者满意度。
患者的平均年龄和随访时间分别为59.1岁和57.9个月。700CX™和泰坦IPP的EDITS评分没有差异(分别为77.2±12.1和77.5±16.6,p=0.956)。
根据EDITS问卷评估,700CX™和泰坦之间的总体患者满意度没有差异。